Proluma™ PDLLA Launch and CE Certification
2024-02-14
본문
Next-generation collagen biostimulator: Proluma™ PDLLA 200 mg
Paris, France — 14 February 2024 — Genèse Labs has launched Proluma™ PDLLA, an injectable collagen stimulator built on polymer technology developed at the company’s French headquarters, together with completion of the Proluma™ trademark registration.
- PrevGenèse Labs Unveils Proluma™ 24.03.30
- NextGenèse Labs Announces the Global Launch of RG60® Body Filler 24.01.10




